0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Securinine

Reuben Copperman, MD; Gertrude Copperman, MD; Ara Der Marderosian, PhD
JAMA. 1974;228(3):288. doi:10.1001/jama.1974.03230280016013.
Text Size: A A A
Published online

ABSTRACT

To the Editor.—  In December 1971, E. G. Dimond made reference to research in China on the use of securinine in the treatment of poliomyelitis (218:1552, 1971). Spurred by this reference, we obtained a small amount of the drug and treated one case of amyotropic lateral sclerosis (ALS) with securinine (Pa Med 76:36, 1973). Subsequently, with the permission of the Food and Drug Administration (IND 8929), the drug was administered to eight additional patients, affording us sufficient experience to report our impressions.We do not believe that securinine has any significant effect on the progression of ALS. Not one of our patients experienced a remission, nor did any of our patients show a substantial slowing of the rate of progression. In this respect, our experience probably is in agreement with what must have been the negative experience of the Russian investigators who discovered the drug and who make no reference

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();